# KRESLADI

NDC: 83537-034
Generic name: MARNETEGRAGENE AUTOTEMCEL
Labeler / Manufacturer: Rocket Pharmaceuticals, Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20260326

FDA application: BLA125806

## Active ingredients

- MARNETEGRAGENE AUTOTEMCEL: 6100000 1/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83537-034"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83537-034
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97db9c3c-20c2-4dad-890c-bc821805421f